Recent Developments in the Role of High-Mobility Group Box 1 in Systemic Lupus Erythematosus

被引:41
作者
Schaper, Fleur [1 ]
Westra, Johanna [1 ]
Bijl, Marc [2 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9700 AB Groningen, Netherlands
[2] Martini Hosp, Dept Internal Med & Rheumatol, Groningen, Netherlands
关键词
CONTAINING IMMUNE-COMPLEXES; ANCA-ASSOCIATED VASCULITIS; SERUM-LEVELS; APOPTOTIC CELLS; RHEUMATOID-ARTHRITIS; CYTOKINE RELEASE; DISEASE-ACTIVITY; PROTEIN HMGB1; HIGH-MOBILITY-GROUP-BOX-1; PROTEIN; RENAL MANIFESTATIONS;
D O I
10.2119/molmed.2014.00019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-mobility group box 1 (HMGB1) is an important molecule for several nuclear processes. Recently, HMGB1 has gained much attention as a damage-associated molecular pattern (DAMP) and has been implicated in the pathogenesis of several (auto)immune diseases, in particular, systemic lupus erythematosus (SLE). A main pathogenic feature in SLE is the accumulation of apoptotic cells. Since HMGB1 is released from apoptotic cells it has been hypothesized that HMGB1 might fuel the inflammatory processes, as seen in this disease, and play a fundamental role in the pathogenesis. In this review, we discuss evidence in support of the theory that HMGB1 is an important mediator in SLE and may be considered a new autoantigen.
引用
收藏
页码:72 / 79
页数:8
相关论文
共 76 条
[1]   High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE) [J].
Abdulahad, D. A. ;
Westra, J. ;
Reefman, E. ;
Zuidersma, E. ;
Bijzet, J. ;
Limburg, P. C. ;
Kallenberg, C. G. M. ;
Bijl, M. .
LUPUS, 2013, 22 (06) :597-606
[2]   Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations [J].
Abdulahad, Deena A. ;
Westra, Johanna ;
Bijzet, Johannes ;
Dolff, Sebastian ;
van Dijk, Marcory C. ;
Limburg, Pieter C. ;
Kallenberg, Cees G. M. ;
Bijl, Marc .
ARTHRITIS RESEARCH & THERAPY, 2012, 14 (04)
[3]   High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus [J].
Abdulahad, Deena A. ;
Westra, Johanna ;
Bijzet, Johannes ;
Limburg, Pieter C. ;
Kallenberg, Cees G. M. ;
Bijl, Marc .
ARTHRITIS RESEARCH & THERAPY, 2011, 13 (03)
[4]   High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes [J].
Andersson, U ;
Wang, HC ;
Palmblad, K ;
Aveberger, AC ;
Bloom, O ;
Erlandsson-Harris, H ;
Janson, A ;
Kokkola, R ;
Zhang, MH ;
Yang, H ;
Tracey, KJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (04) :565-570
[5]  
[Anonymous], 2010, J Vis Exp, DOI DOI 10.3791/1724)
[6]   Intracellular HMGB1 Negatively Regulates Efferocytosis [J].
Banerjee, Sami ;
de Freitas, Andressa ;
Friggeri, Arnaud ;
Zmijewski, Jaroslaw W. ;
Liu, Gang ;
Abraham, Edward .
JOURNAL OF IMMUNOLOGY, 2011, 187 (09) :4686-4694
[7]   The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis [J].
Banerjee, Sami ;
Friggeri, Arnaud ;
Liu, Gang ;
Abraham, Edward .
JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 88 (05) :973-979
[8]   Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus [J].
Barkauskaite, V. ;
Ek, M. ;
Popovic, K. ;
Harris, H. E. ;
Wahren-Herlenius, M. ;
Nyberg, F. .
LUPUS, 2007, 16 (10) :794-802
[9]   Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock [J].
Barnay-Verdier, Stephanie ;
Fattoum, Lakhdar ;
Borde, Chloe ;
Kaveri, Srini ;
Gibot, Sebastien ;
Marechal, Vincent .
INTENSIVE CARE MEDICINE, 2011, 37 (06) :957-962
[10]  
Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO